文献速递皮肤肿瘤

原发性黑色素瘤诊断后医疗利用的时间趋势:Medicare受益者研究

Temporal trends in healthcare utilization following primary melanoma diagnosis among Medicare beneficiaries.
PubMed 文献 · Br J Dermatol · 2017-07-09

本研究基于SEER-Medicare数据库,纳入2000-2009年诊断的56 254例≥66岁原发性黑色素瘤患者,采用前后多次时间序列分析,评估诊断后3-6个月和6-24个月的医疗利用趋势。结果显示诊断后24个月皮肤活检率和皮肤科就诊率显著增加,而良性皮肤切除和内科就诊保持稳定。

要点

  • 良性皮肤切除和内科就诊率随时间保持稳定。

核心结论

  • 原发性黑色素瘤诊断后皮肤活检和皮肤科就诊的利用率随时间显著增加。

研究设计与样本

  • 基于SEER-Medicare数据库的前后多次时间序列研究,纳入2000-2009年诊断的56 254例≥66岁原发性黑色素瘤患者。

主要发现

  • 良性皮肤切除和内科就诊率保持稳定。
  • 皮肤科就诊趋势与皮肤活检相似。

临床怎么用

  • 结果可能有助于优化Medicare人群中黑色素瘤的医疗服务质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Little is known about the impact of primary melanoma diagnosis on healthcare utilization and changes in utilization over time. OBJECTIVES: To evaluate population-based temporal trends in healthcare utilization following primary melanoma diagnosis. METHODS: We conducted a before-and-after multiple time series study of Medicare beneficiaries aged ≥ 66 years with primary melanoma diagnoses between 2000 and 2009 using the Surveillance, Epidemiology, and End Results Medicare database. Primary exposure was time from primary melanoma diagnosis at 3-6 months and 6-24 months postdiagnosis. Covariates included tumour-, patient- and geographical-level characteristics and healthcare utilization in the 6 months before diagnosis. Poisson regression was used to estimate population-based risk-adjusted utilization rates for skin biopsies, benign skin excisions, internal medicine office visits and dermatology office visits. RESULTS: The study population included 56 254 patients with first diagnoses of primary melanoma. Most patients were ≥ 75 years old (56·8%), male (62·1%), and had in situ melanoma (42·4%) or localized invasive melanoma (45·9%). From 2000 to 2009, risk-adjusted skin biopsy rates 24 months postdiagnosis increased from 358·3 to 541·3 per 1000 person-years (P < 0·001), and dermatology visits increased from 989·0 to 1535·6 per 1000 person-years (P < 0·001). Benign excisions and internal medicine visits remained stable. In 2000, risk-adjusted skin biopsy rates 6 months postdiagnosis increased by 208·5 relative to the 6 months before diagnosis (148·7 vs. 357·2) compared with an observed absolute increase of 272·5 (290·9 vs. 563·1) in 2009. Trends in dermatology visits were similar. CONCLUSIONS: Utilization of skin biopsies and dermatology office visits following primary melanoma diagnosis has increased substantially over time. These results may inform optimization of care delivery for melanoma within the Medicare population.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Lott JP, Wang Q, Titus LJ, et al. Temporal trends in healthcare utilization following primary melanoma diagnosis among Medicare beneficiaries. Br J Dermatol. 2017. PMID: 28369774. doi:10.1111/bjd.15530

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。